Try our Advanced Search for more refined results

Fosun Pharma Unit Inks $533M Deal To Sell Medical IP Rights

By Chelsea Naso (October 23, 2013, 3:18 PM EDT) -- Shanghai Fosun Pharmaceutical Group Co. Ltd. subsidiary Chongqing Fochon Pharmaceutical Co. Ltd. will sell intellectual property rights to two medical compounds believed to be the early makings of diabetes and cancer treatments for €388 million ($533 million) to clinical research company Sellas Clinicals Holding AG, the companies announced Wednesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!